SCHEMBL6227475

SCHEMBL6227475

[2H]C1=CC2=CC3=NC(=CC4=NC(=CC5=NC(=CC1=N2)C=C5)C=C4Br)C=C3Br.[Zn]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL78010 0.70 — —
SCHEMBL8172667 0.68 — —
SCHEMBL1275382 0.66 MAOA (0.31) —
Iodide SCHEMBL1410331 0.65 — —
SCHEMBL335627 0.65 — —
Hydrochloric Acid SCHEMBL8209580 0.65 — —
SCHEMBL3818292 0.65 — —
SCHEMBL11569700 0.65 LMNA (0.31) —
SCHEMBL10664990 0.63 — —
SCHEMBL28306376 0.62 MAOA (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050137180-A1 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy MIRAVANT PHARMACEUTICALS, INC. 2005-06-23 — — US claimed
EP-1401506-A4 METALLOTETRAPYRROLIC PHOTOSENSITIZING AGENTS FOR USE IN PHOTODYNAMIC THERAPY MIRAVANT PHARM INC (US) 2005-02-16 — — EP claimed
EP-1401506-A2 METALLOTETRAPYRROLIC PHOTOSENSITIZING AGENTS FOR USE IN PHOTODYNAMIC THERAPY Miravant Pharmaceuticals, Inc. (US) 2004-03-31 — — EP claimed
US-20030105069-A1 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy MIRAVANT PHARMACEUTICALS, INC. 2003-06-05 — — US claimed
WO-2002096366-A2 METALLOTETRAPYRROLIC PHOTOSENSITIZING AGENTS FOR USE IN PHOTODYNAMIC THERAPY MIRAVANT PHARMACEUTICALS, INC. (US) 2002-12-05 — — WO claimed
Send feedback